Stem cell treatment for severe or critical COVID-19
Part of Infections, Lungs & breathing clinical trials.
This trial tests donated (allogeneic) fat-derived stem cells to see if they improve outcomes in adults with severe or critical COVID-19. It may help calm severe lung/immune problems, but whether it works and is safe will be studied in this Phase 2 study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older and can sign consent before any study procedures
- You have COVID-19 confirmed by a positive PCR test
- Your doctor says your COVID-19 is severe or critical
- You are well enough for infusion right now (not medically unstable, like very uncontrolled blood pressure or very unstable oxygen levels)
- You have no recent major trauma or surgery in the last 14 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests immune cells from a matched family donor (made to target the COVID-19 virus) to see if they can help people with mild-to-moderate COVID-19 who are hospitalized and at higher risk for getting sicker. It aims to check safety first and also look for signs of benefit.
This Phase 2 study tests whether donated-from-your-own-fat stem cells can improve outcomes for people who are high risk for getting COVID-19, but who have never had COVID-19 and test negative right now. It may help your immune system and reduce complications if you become infected during the study.
This trial tests a new medicine made from stem cells to see if it can help people with COVID-19 symptoms. It's for people who are overweight or moderately obese, have had symptoms for a few days, and have tested positive for COVID-19.
This study tests whether a single infusion of mesenchymal stem cells can help with Long COVID symptoms—without causing serious side effects. It’s for people who are still struggling with COVID-related health problems months after their initial infection.
This trial tests a new stem cell therapy for people with moderate to severe COPD who have not improved with standard treatments. The goal is to see if the therapy is safe and can help improve lung function.
This trial tests if adding stem cells or their growth liquid to standard sepsis treatment helps adults with severe breathing problems. It may improve recovery for those whose family agrees to the study.
Hear when a new Corona Virus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.